Intraoperative imaging of positron emission tomographic radiotracers using cerenkov luminescence emissions

Molecular Imaging

Volumn 10, Issue 3, 2011, Pages 177-186

  Holland, Jason P ^a   Normand, Guillaume ^a   Ruggiero, Alessandro ^a   Lewis, Jason S ^a   Grimm, Jan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; CERENKOV; CERENKOV RADIATION; CLINICAL TOOLS; COMPETITIVE INHIBITION; IMAGE-GUIDED; IMMUNOREACTIVITIES; IN-VIVO; INTRA-OPERATIVE; LUMINESCENCE EMISSION; LUMINESCENCE IMAGING; MOLECULAR IMAGING; OPTICAL EMISSIONS; PET IMAGES; POSITRON EMISSION; QUANTITATIVE IMAGING; QUANTITATIVE INFORMATION; REAL-TIME INFORMATION; SURGICAL PROCEDURES; SURGICAL RESECTION; TOMOGRAPHIC; TRASTUZUMAB;

ELECTRONS; LUMINESCENCE; MONOCLONAL ANTIBODIES; POSITRONS; RADIOACTIVE TRACERS; SURGERY; TUMORS; ZIRCONIUM;

POSITRON EMISSION TOMOGRAPHY;

DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; RADIOISOTOPE; TRASTUZUMAB;

ANIMAL; ARTICLE; DRUG EFFECT; HUMAN; LUMINESCENCE; METHODOLOGY; MOUSE; NEOPLASM; PEROPERATIVE CARE; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TIME; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; HUMANS; INTRAOPERATIVE CARE; LUMINESCENCE; MICE; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 79954999842     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00047     Document Type: Article

References (23)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41. (Pubitemid 35176242)
2. Balch GC, Mithani SK, Simpson JK, Kelley MC. Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy. Am Surg 2005;71:22-7.
3. Chagpar A, Yen T, Sahin A, et al. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg 2003;186:371-7. (Pubitemid 38368613)
4. Vermeeren L, Meinhardt W, Bex A, et al. Paraaortic sentinel lymph nodes: toward optimal detection and intraoperative localization using SPECT/CT and intraoperative real-time imaging. J Nucl Med 2010;51:376-82.
5. Vermeeren L, Valdes Olmos RA, Klop WMC, et al. A portable gcamera for intraoperative detection of sentinel nodes in the head and neck region. J Nucl Med 2010;51:700-3.
6. Robertson R, Germanos MS, Li C, et al. Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys Med Biol 2009;54:N355-65.
7. Ruggiero A, Holland JP, Lewis JS, Grimm J. Cerenkov luminescence imaging of medical isotopes. J Nucl Med 2010;51:1123-30.
8. Cho JS, Taschereau R, Olma S, et al. Cerenkov radiation imaging as a method for quantitative measurements of beta particles in a microfluidic chip. Phys Med Biol 2009;54:6757-71.
9. Spinelli AE, D'Ambrosio D, Calderan L, et al. Cerenkov radiation allows in vivo optical imaging of positron emitting radiotracers. Phys Med Biol 2010;55:483-95.
10. Liu H, Ren G, Miao Z, et al. Molecular optical imaging with radioactive probes. PLoS One 2010;5:e9470.
11. Li C, Mitchell G, Cherry S. Cerenkov luminescence tomography for small animal imaging. Opt Lett 2010;35:1109-11.
12. Holland JP, Williamson MJ, Lewis JS. Unconventional nuclides for radiopharmaceuticals. Mol Imaging 2010;9:1-20.
13. 89Zr-DFO-J591 for immunoPET imaging of prostate-specific membrane antigen (PSMA) expression in vivo. J Nucl Med 2010. [In press] DOI: 10.2967/jnumed.110.076174.
14. 89Zr-DFO-trastuzumab. PLoS One 2010; 5:e8859.
15. Zanzonico P. Routine quality control of clinical nuclear medicine instrumentation: a brief review. J Nucl Med 2009;49: 1114-31. (Pubitemid 351948020)
16. Holland JP, Sheh Y, Lewis JS. Standardized methods for the production of high specific-activity zirconium-89. Nucl Med Biol 2009;36:729-39.
17. Lindmo T, Boven E, Cuttitta F, et al. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 1984;72:77-89. (Pubitemid 14091996)
18. National Institutes of Health. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1966.
19. Kim JS, Lee JS, Im KC, et al. Performance measurement of the microPET Focus 120 scanner. J Nucl Med 2007;48:1527-35.
20. 89Zr-trastuzumab for HER2/neu immunoPET imaging. J Nucl Med 2009;50: 974-81.
21. 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther 2010;87:586-92.
22. 89Zr- trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft. Eur J Cancer 2010;46:678-84.
23. Cherry SR, Sorenson JA, Phelps ME. Physics in nuclear medicine. 3rd ed. Saunders; 2003.